SI9300461B - Beads having a core coated with an antifugal and a polymer - Google Patents

Beads having a core coated with an antifugal and a polymer Download PDF

Info

Publication number
SI9300461B
SI9300461B SI9300461A SI9300461A SI9300461B SI 9300461 B SI9300461 B SI 9300461B SI 9300461 A SI9300461 A SI 9300461A SI 9300461 A SI9300461 A SI 9300461A SI 9300461 B SI9300461 B SI 9300461B
Authority
SI
Slovenia
Prior art keywords
antifungal agent
polymer
core
hydrophilic polymer
microspheres
Prior art date
Application number
SI9300461A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9300461A (en
Inventor
Paul Marie Victor Gilis
Conde Valentin Florent Vict De
Roger Petrus Gerebe Vandecruys
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9300461(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI9300461A publication Critical patent/SI9300461A/sl
Publication of SI9300461B publication Critical patent/SI9300461B/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Materials For Medical Uses (AREA)
SI9300461A 1992-09-03 1993-09-03 Beads having a core coated with an antifugal and a polymer SI9300461B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92202664 1992-09-03

Publications (2)

Publication Number Publication Date
SI9300461A SI9300461A (en) 1994-03-31
SI9300461B true SI9300461B (en) 2001-12-31

Family

ID=8210890

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300461A SI9300461B (en) 1992-09-03 1993-09-03 Beads having a core coated with an antifugal and a polymer

Country Status (33)

Country Link
US (1) US5633015A (cs)
EP (1) EP0658103B1 (cs)
JP (1) JP2865869B2 (cs)
KR (1) KR0151893B1 (cs)
CN (1) CN1034714C (cs)
AP (1) AP444A (cs)
AT (1) ATE145327T1 (cs)
AU (1) AU665867B2 (cs)
CA (1) CA2142848C (cs)
CY (1) CY2105B1 (cs)
CZ (1) CZ283403B6 (cs)
DE (1) DE69306119T2 (cs)
DK (1) DK0658103T3 (cs)
ES (1) ES2097536T3 (cs)
FI (1) FI112437B (cs)
GR (1) GR3022198T3 (cs)
HK (1) HK1006000A1 (cs)
HR (1) HRP931158B1 (cs)
HU (1) HU220614B1 (cs)
IL (1) IL106871A (cs)
MX (1) MX9305438A (cs)
MY (1) MY109369A (cs)
NO (1) NO307953B1 (cs)
NZ (1) NZ255379A (cs)
OA (1) OA10130A (cs)
PH (1) PH30929A (cs)
PL (2) PL172676B1 (cs)
RU (1) RU2125445C1 (cs)
SG (1) SG48801A1 (cs)
SI (1) SI9300461B (cs)
TW (1) TW376322B (cs)
WO (1) WO1994005263A1 (cs)
ZA (1) ZA936493B (cs)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
AU5655196A (en) 1995-05-09 1996-11-29 Colorcon Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
ATE255883T1 (de) 1996-05-20 2003-12-15 Janssen Pharmaceutica Nv Fungizide mittel mit verbesserter bioverfügbarkeit
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
AU734248B2 (en) * 1997-03-26 2001-06-07 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
KR100514330B1 (ko) * 1997-12-31 2006-02-17 주식회사 중외제약 난용성 약물을 함유하는 코팅정
DE69808670T2 (de) * 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
CA2315110C (en) * 1998-07-17 2006-09-12 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DK1163234T3 (da) 1999-03-24 2006-02-27 Scherer Technologies Inc R P Farmaceutiske formuleringer med forbedret vandoplöselighed
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
PT1239831E (pt) * 1999-12-23 2013-01-23 Mayne Pharma International Pty Ltd Composições farmacêuticas melhoradas para fármacos fracamente solúveis
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
CN1813753B (zh) * 2000-02-29 2010-04-07 布里斯托尔-迈尔斯斯奎布公司 低剂量艾替开韦制剂及其应用
US6551608B2 (en) * 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6673373B2 (en) * 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
KR100870184B1 (ko) 2001-02-14 2008-11-24 티보텍 파마슈티칼즈 리미티드 광범위 2-(치환된-아미노)-벤조티아졸 설폰아미드 ｈｉｖ프로티아제 억제제
JP4417010B2 (ja) 2001-04-09 2010-02-17 テイボテク・フアーマシユーチカルズ・リミテツド 広範囲２−（置換−アミノ）−ベンズオキサゾールスルホンアミドｈｉｖプロテアーゼ阻害剤
ATE429431T1 (de) 2001-05-11 2009-05-15 Tibotec Pharm Ltd 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
KR100438485B1 (ko) * 2001-08-13 2004-07-09 한국디디에스제약 주식회사 아졸류 항진균제의 약제학적 조성물
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
CA2363376A1 (en) * 2001-11-16 2003-05-16 Bernard Charles Sherman Solid pharmaceutical compositions for oral administration comprising itraconazole
CN100448444C (zh) 2001-12-21 2009-01-07 泰博特克药品有限公司 含杂环取代苯基的磺酰胺广谱hiv蛋白酶抑制剂
MXPA04007435A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Metodo para preparar dispersiones solidas amorfas de farmacos secadas por pulverizacion utilizando inyectores a presion.
US7078526B2 (en) * 2002-05-31 2006-07-18 Transform Pharmaceuticals, Inc. CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
WO2003074474A2 (en) 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7446107B2 (en) * 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
HRP20050607B1 (hr) 2002-05-17 2014-07-04 Tibotec Pharmaceuticals Ltd. Supstituirani benzizoksazol sulfonamid hiv proteazni inhibitori širokog spektra
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2006500377A (ja) * 2002-06-21 2006-01-05 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 改善された溶解性を有する医薬組成物
AU2003256089A1 (en) * 2002-07-22 2004-02-09 Nanohybrid Co., Ltd. Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
WO2004016619A1 (en) 2002-08-14 2004-02-26 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
WO2004047778A1 (en) 2002-11-26 2004-06-10 Uc Tech Materials and methods for preventing and treating microbe-mediated epithelial disorders
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
ES2283724T5 (es) * 2003-01-14 2013-04-09 Acino Pharma Ag Composición de itraconazol dispersada en un polímero hidrófilo con biodisponibilidad potenciada
SI1438961T2 (sl) † 2003-01-14 2014-12-31 Cimex Pharma Ag Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
SG145742A1 (en) 2003-09-11 2008-09-29 Tibotec Pharm Ltd Entry inhibitors of the hiv virus
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
CA2558027A1 (en) * 2004-03-03 2005-09-15 Spherics, Inc. Polymeric drug delivery system for hydrophobic drugs
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
WO2005110428A2 (en) 2004-05-07 2005-11-24 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
BRPI0511173A (pt) 2004-05-17 2007-12-04 Tibotec Pharm Ltd 1-fenil-1,5-diidro-pirido-(3,2b)indol-2-onas substituìdas nas posições 6,7,8,9, de utilidade como agentes farmacêuticos antiinfecciosos
EA012330B1 (ru) 2004-05-17 2009-08-28 Тиботек Фармасьютикалз Лтд. 1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ
JP4879889B2 (ja) 2004-05-17 2012-02-22 テイボテク・フアーマシユーチカルズ・リミテツド ４−置換−１，５−ジヒドロ−ピリド［３，２−ｂ］インドール−２−オン
WO2006026504A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
US20100297251A1 (en) * 2004-09-01 2010-11-25 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
US20100297248A1 (en) * 2004-09-01 2010-11-25 Board Of Regents, The University Of Texas System Encapsulated particles for amorphous stability enhancement
US20060045822A1 (en) * 2004-09-01 2006-03-02 Board Of Regents, The University Of Texas System Plasma polymerization for encapsulating particles
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
TW200710091A (en) 2005-04-11 2007-03-16 Tibotec Pharm Ltd (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
JP2009502258A (ja) * 2005-07-21 2009-01-29 ノミール・メディカル・テクノロジーズ・インコーポレーテッド 標的部位の生物学的汚染物質のレベルを下げる方法
US20070148240A1 (en) * 2005-12-23 2007-06-28 Fang-Yu Lee Oral formulation containing itraconazole and methods for manufacturing and using the same
CA2646090A1 (en) 2006-04-03 2007-10-11 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
CN101091725A (zh) * 2006-06-23 2007-12-26 天津天士力制药股份有限公司 一种中药颗粒及其制备方法
EP2134327A1 (en) * 2007-03-13 2009-12-23 Sandoz AG Pharmaceutical compositions of poorly soluble drugs
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US7314641B1 (en) 2007-04-18 2008-01-01 Everest Pharm. Industrial Co., Ltd. High-bioavailability particle coated with fungicide and polymer
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
BRPI0819883A2 (pt) 2007-11-28 2017-05-23 Sequoia Pharmaceuticals Inc composições e métodos para inibir citocromo p450 2d6
WO2009105776A1 (en) 2008-02-21 2009-08-27 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
US8088451B2 (en) 2008-03-13 2012-01-03 Board Of Regents, The University Of Texas System Covalently functionalized particles for synthesis of new composite materials
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
GB2479213B (en) * 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
RU2734128C2 (ru) * 2010-12-16 2020-10-13 Плэтформ Брайтворкс Ту,Лтд Фармацевтические препараты азолов для парентерального введения и способы их получения и применения для лечения заболеваний, чувствительных к азольным соединениям
CA2835277A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
KR20210043721A (ko) 2012-06-21 2021-04-21 메인 파마 인터내셔널 프로프라이어터리 리미티드 이트라코나졸 조성물 및 투여형, 그리고 이것들의 사용 방법
CN103948911B (zh) * 2014-04-23 2016-04-20 深圳市健元医药科技有限公司 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
EP3405191B1 (en) 2016-01-20 2025-02-19 TheraVida, Inc. Compositions for use in treating hyperhidrosis
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US5049374A (en) * 1989-11-28 1991-09-17 Dansereau Richard J Oral (coated bead) dosage form for sodium iodide I-131
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions

Also Published As

Publication number Publication date
WO1994005263A1 (en) 1994-03-17
NO307953B1 (no) 2000-06-26
OA10130A (en) 1996-12-18
NZ255379A (en) 1996-06-25
IL106871A (en) 1998-02-22
HUT70419A (en) 1995-10-30
PL307791A1 (en) 1995-06-26
HRP931158A2 (en) 1995-06-30
PL172676B1 (pl) 1997-11-28
KR0151893B1 (ko) 1998-10-15
ZA936493B (en) 1995-03-02
DE69306119D1 (de) 1997-01-02
JP2865869B2 (ja) 1999-03-08
NO950829L (no) 1995-05-02
CZ283403B6 (cs) 1998-04-15
FI112437B (fi) 2003-12-15
HRP931158B1 (en) 1999-02-28
ES2097536T3 (es) 1997-04-01
CZ54295A3 (en) 1995-09-13
ATE145327T1 (de) 1996-12-15
PH30929A (en) 1997-12-23
NO950829D0 (no) 1995-03-02
CY2105B1 (en) 2002-04-26
IL106871A0 (en) 1993-12-28
HU9500642D0 (en) 1995-04-28
AP9300563A0 (en) 1993-10-31
RU2125445C1 (ru) 1999-01-27
SG48801A1 (en) 1998-05-18
DE69306119T2 (de) 1997-03-13
CN1088432A (zh) 1994-06-29
SI9300461A (en) 1994-03-31
PL174178B1 (pl) 1998-06-30
EP0658103A1 (en) 1995-06-21
MX9305438A (es) 1994-03-31
MY109369A (en) 1997-01-31
CA2142848C (en) 1999-11-16
AP444A (en) 1996-01-19
CN1034714C (zh) 1997-04-30
FI950975A0 (fi) 1995-03-02
EP0658103B1 (en) 1996-11-20
AU665867B2 (en) 1996-01-18
DK0658103T3 (da) 1996-12-09
GR3022198T3 (en) 1997-03-31
CA2142848A1 (en) 1994-03-17
JPH08501092A (ja) 1996-02-06
HU220614B1 (hu) 2002-03-28
FI950975L (fi) 1995-03-02
AU4954693A (en) 1994-03-29
TW376322B (en) 1999-12-11
HK1006000A1 (en) 1999-02-05
US5633015A (en) 1997-05-27

Similar Documents

Publication Publication Date Title
SI9300461B (en) Beads having a core coated with an antifugal and a polymer
RU2218153C2 (ru) Драже, имеющее ядро, покрытое противогрибковым средством и полимером
RU95108537A (ru) Гранула, способ ее получения и фармацевтическая композиция
RU99112123A (ru) Драже, имеющее ядро, покрытое противогрибковым средством и полимером
CA2153856C (en) Duloxetine enteric pellets
US5084287A (en) Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
KR950005864B1 (ko) 서방성 제제 및 그의 제조방법
Dey et al. Multiparticulate drug delivery systems for controlled release
FI102515B (fi) Asymmetrisiä kalvoja käsittävä väline, joka pystyy kontrolloidusti vap auttamaan aktiivista ainetta sekä menetelmiä välineiden valmistamiseks i
ES2428064T3 (es) Sistemas de liberación pulsátil controlada
US3492397A (en) Sustained release dosage in the pellet form and process thereof
US6627223B2 (en) Timed pulsatile drug delivery systems
EP0593552B1 (en) Process for preparing drug substances in beadlet form
RU2000120913A (ru) Гранулы, имеющие ядро, покрытое противогрибковым препаратом и полимером
CZ279809B6 (cs) Farmaceutický přípravek skládající se z granulí obsahujících tetracyklinovou sloučeninu
US20030185887A1 (en) Controlled release oral dosage form of beta-adrenergic blocking agents
US20090117232A1 (en) Lipoic acid pellets
AU2004287373A2 (en) Stable lansoprazole formulation
GB2207052A (en) Controlled release osmotic device
ZA200505180B (en) Process for manufacturing sustained release microbeads containing venlafaxine HCI
CN108785270A (zh) 一种干粉包衣胶囊制剂的方法
Li et al. The effect of polymer coating systems on the preparation, tableting, and dissolution properties of sustained-release drug pellets
JP3456211B2 (ja) 持続性製剤
UA59394C2 (uk) Стійка у фіксованих дозах оральна фармацевтична композиція, що містить антибактеріальний засіб і мікроорганізм одночасно, та спосіб її одержання (варіанти)
CA1268710A (en) Drug in bead form and process for preparing same

Legal Events

Date Code Title Description
IF Valid on the event date